Literature DB >> 27757568

Bone mineral density and vitamin D status in children with epilepsy, cerebral palsy, and cerebral palsy with epilepsy.

Ayse Tosun1, Seda Erisen Karaca2, Tolga Unuvar3, Yakup Yurekli4, Cigdem Yenisey5, Imran Kurt Omurlu6.   

Abstract

PURPOSE: We aimed to evaluate the relationship between bone mineral density (BMD) disorders and possible risk factors in patients with epilepsy only (EO), cerebral palsy only (CPO), and cerebral palsy-epilepsy (CP + E).
METHODS: A total of 122 patients [EO (n = 54), CPO (n = 30), CP + E (n = 38)] and 30 healthy children were evaluated. BMD was only measured in patient groups, not in control subjects. BMD of lumbar vertebrae was determined by dual energy X-ray absorptiometry (DXA). An abnormal BMD was defined as low or low normal BMD.
RESULTS: Low BMD rate in EO, CPO, and CP + E group was 3.7, 50, and 39.5 %, respectively. Abnormal BMD values were significantly related to inadequate dietary Ca intake (p = 0.017), severe intellectual disability (p < 0.001), and immobility (p = 0.018). In multivariate regression analysis, the risk of abnormal BMD was higher (3.9-fold) in patients not able to walk independently than the others (p = 0.029). However, serum Ca-Vitamin D levels, insufficient exposure to sunlight, low BMI, and use of AED were not correlated with abnormal BMD.
CONCLUSION: Abnormal BMD is a common problem in patients with CP and CP + E. Abnormal BMD was related to the severity of CP, but not to vitamin D levels or AED treatment.

Entities:  

Keywords:  Bone mineral density; Cerebral palsy; Children; Epilepsy; Vitamin D

Mesh:

Substances:

Year:  2016        PMID: 27757568     DOI: 10.1007/s00381-016-3258-0

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  26 in total

1.  Mortality in second and third degree malnutrition. 1956.

Authors:  F Gómez; R Ramos Galvan; S Frenk; J Cravioto Muñoz; R Chávez; J Vázquez
Journal:  Bull World Health Organ       Date:  2000       Impact factor: 9.408

2.  Evaluation of bone turnover in epileptic children using oxcarbazepine.

Authors:  Ali Cansu; Ediz Yesilkaya; Ayşe Serdaroğlu; Tuğba Lüleci Hirfanoğlu; Orhun Camurdan; Ozlem Gülbahar; Kivilcim Gücüyener; Peyami Cinaz
Journal:  Pediatr Neurol       Date:  2008-10       Impact factor: 3.372

3.  The CP-MST, a malnutrition screening tool for institutionalized adult cerebral palsy patients.

Authors:  Irène Benigni; Patrick Devos; Thierry Rofidal; David Seguy
Journal:  Clin Nutr       Date:  2011-07-20       Impact factor: 7.324

Review 4.  Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease.

Authors:  Michael F Holick
Journal:  Am J Clin Nutr       Date:  2004-12       Impact factor: 7.045

5.  Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years.

Authors:  G Kafali; T Erselcan; F Tanzer
Journal:  Clin Pediatr (Phila)       Date:  1999-02       Impact factor: 1.168

Review 6.  Systematic review of interventions for low bone mineral density in children with cerebral palsy.

Authors:  Janet P Hough; Roslyn N Boyd; Jennifer L Keating
Journal:  Pediatrics       Date:  2010-02-01       Impact factor: 7.124

7.  Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy.

Authors:  Richard C Henderson; Robert K Lark; Matthew J Gurka; Gordon Worley; Ellen B Fung; Mark Conaway; Virginia A Stallings; Richard D Stevenson
Journal:  Pediatrics       Date:  2002-07       Impact factor: 7.124

Review 8.  Management of osteoporosis in children.

Authors:  Nicholas J Shaw
Journal:  Eur J Endocrinol       Date:  2008-09-04       Impact factor: 6.664

9.  Bone mineral density in a population of children and adolescents with cerebral palsy and mental retardation with or without epilepsy.

Authors:  Giangennaro Coppola; Delia Fortunato; Ciro Mainolfi; Francesco Porcaro; Davide Roccaro; Giuseppe Signoriello; Francesca Felicia Operto; Alberto Verrotti
Journal:  Epilepsia       Date:  2012-09-07       Impact factor: 5.864

10.  Vitamin D levels in children and adolescents with antiepileptic drug treatment.

Authors:  Jung-Hyun Baek; Young-Ho Seo; Gun-Ha Kim; Mi-Kyung Kim; Baik-Lin Eun
Journal:  Yonsei Med J       Date:  2014-03       Impact factor: 2.759

View more
  5 in total

Review 1.  Antiepileptic Drugs and Bone Health: Current Concepts.

Authors:  Antonio Siniscalchi; Sean Murphy; Erika Cione; Leonardo Piro; Giovambattista De Sarro; Luca Gallelli
Journal:  Psychopharmacol Bull       Date:  2020-05-19

Review 2.  Multivariate Analysis and Machine Learning in Cerebral Palsy Research.

Authors:  Jing Zhang
Journal:  Front Neurol       Date:  2017-12-21       Impact factor: 4.003

3.  Vitamin D Status in Children on Anticonvulsant Therapy.

Authors:  Madhava Vijayakumar; Ajitha Bk; Biju George; Vijayalakshmi Bhatia
Journal:  Indian J Pediatr       Date:  2021-07-28       Impact factor: 1.967

4.  Measurement of Bone Mineral Density in Children with Cerebral Palsy from an Ethical Issue to a Diagnostic Necessity.

Authors:  Jasmin S Nurković; Pavle Petković; Danijela Tiosavljević; Radiša Vojinović
Journal:  Biomed Res Int       Date:  2020-09-19       Impact factor: 3.411

5.  Vitamin D deficiency in pediatric patients using antiepileptic drugs: systematic review with meta-analysis.

Authors:  Cíntia Junges; Tania Diniz Machado; Paulo Ricardo Santos Nunes Filho; Rudimar Riesgo; Elza Daniel de Mello
Journal:  J Pediatr (Rio J)       Date:  2020-03-12       Impact factor: 2.990

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.